Market Tracker

04/17 5:16pm ET

Merck & Co Inc (NYSE:MRK)

During the Trading Day
56.47 +0.21 / +0.37%
Data as of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
56.26 -0.21 / -0.37%
 
Volume: 303.0K
Johnson & Johnson's 3 Major Strengths
2:30pm / MotleyFool.com
Top 40 Upcoming Earnings Releases
Apr 11 / Benzinga
If This Biotech Drops Much Further I'm Going to Buy It!
1:05pm / MotleyFool.com
Google Honors Chemist Percy Julian & His Contributions
Apr 11 / Benzinga
Will Merck & Co. Inc Unseat Biotech's Hottest Drug?
9:31am / MotleyFool.com
JPMorgan's Earnings Disaster Drops the Dow 100 Points
Apr 11 / MotleyFool.com
2 Reasons Why Merck & Co. Is Crushing the Dow
Apr 16 / MotleyFool.com
3 Drugs Stocks Driving The Industry Higher
Apr 11 / TheStreet.com
Gilead Sciences, Inc. Feeling Sovaldi Pressure From All Sides
Apr 16 / MotleyFool.com
The Four Types of Growth Stocks
Apr 11 / TheStreet.com
Could This Small-Cap Biotech's Experimental Diabetes Drug Be a Game Changer?
Apr 16 / MotleyFool.com
Dow 30 Stock Roundup: Pfizer Drug Trial Dents, P&G Ups Dividend - Analyst Blog
Apr 11 / Zacks.com
Jim Cramer's Top Stock Picks: WFM SBUX MRK STZ
Apr 16 / TheStreet.com
Jim Cramer's Mad Dash: HRB GILD
Apr 11 / TheStreet.com
How Much Has Merck Shaken Up the Hepatitis C Race?
Apr 15 / MotleyFool.com
Merck Shouts "Me, Too!" But Will It Matter?
Apr 11 / MotleyFool.com
Eli Lilly/ Boehringer Drug Under FDA Review - Analyst Blog
Apr 15 / Zacks.com
US Stock Futures Slip Ahead Of Consumer Sentiment Report
Apr 11 / Benzinga
FDA Nod for Merck's Grastek - Analyst Blog
Apr 15 / Zacks.com
Merck Up on Encouraging HCV Data - Analyst Blog
Apr 10 / Zacks.com
Leaders Of The Pharmaceutical Pack
Apr 15 / StockTwits
May 30th Options Now Available For Merck (MRK)
Apr 10 / TheStreet.com
Does Pfizer Offer Good Value?
Apr 15 / MotleyFool.com
Dow Today: Merck (MRK) Leads The Day Higher, Chevron (CVX) Lags
Apr 10 / TheStreet.com
This Forgotten Pharma Could Be a Hit for Your Portfolio
Apr 15 / MotleyFool.com
Why Merck (MRK) Stock Is Higher This Morning
Apr 10 / TheStreet.com
3 Health Care Stocks Bucking the S&P Downtrend
Apr 15 / MotleyFool.com
US Stock Futures Edge Lower Ahead Of Jobless Claims Data
Apr 10 / Benzinga
Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences Inc. for H...
Apr 15 / MotleyFool.com
Today's Pre-Market Trading Very Positive For Merck (MRK)
Apr 10 / TheStreet.com
Amgen's Conundrum
Apr 14 / MotleyFool.com
Today's Biotech Stocks to Watch: Bristol-Myers Squibb, Gilead Sciences and Merck & Co...
Apr 10 / MotleyFool.com
Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog
Apr 14 / Zacks.com
Why the Dow Jones Jumped 180 Points Today
Apr 09 / MotleyFool.com
Market Wrap For April 14: Markets Surge on Positive Retail Data, Citi Earnings
Apr 14 / Benzinga
Merck Moves the Dow and Facebook Pops as Earnings Season Gets Started
Apr 09 / MotleyFool.com
Markets Falling? Get Your Defense Ready
Apr 14 / Benzinga
EPO Upholds Alnylam's McSwiggen Patent - Analyst Blog
Apr 08 / Zacks.com
Dow Today: International Business Machines (IBM) Leads The Day Higher, Merck (MRK) La...
Apr 14 / TheStreet.com
Update on Merck's MK-3475 - Analyst Blog
Apr 08 / Zacks.com
3 Stocks Reiterated As A Buy: MDLZ, MRK, MCD
Apr 14 / TheStreet.com
Merck Launches Hail Mary Lung Cancer Trial
Apr 08 / MotleyFool.com
Is This the Answer to Expensive Hepatitis-C Cures?
Apr 14 / MotleyFool.com
Takeda and Eli Lilly fall foul of jury in Actos trial
Apr 08 / FT.com
Johnson & Johnson Earnings: Will Tuesday Bring More Good News for J&J?
Apr 14 / MotleyFool.com
Takeda: a fine mess
Apr 08 / FT.com
One Put, One Call Option To Know About For Merck & Co.
Apr 14 / TheStreet.com
The Biggest Biotech Clinical Wins of the Week
Apr 08 / MotleyFool.com
No Legwork Mondays b Merck And Vioxx
Apr 14 / Benzinga
Can J&J's Pharma Segment Deliver Meaningful Growth?
Apr 07 / MotleyFool.com